Pearl Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Pearl Therapeutics's estimated annual revenue is currently $4.4M per year.
- Pearl Therapeutics's estimated revenue per employee is $100,500
- Pearl Therapeutics's total funding is $255.5M.
Employee Data
- Pearl Therapeutics has 44 Employees.
- Pearl Therapeutics grew their employee count by 0% last year.
Pearl Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | Associate Director | Reveal Email/Phone |
3 | Associate Director, Process Engineering | Reveal Email/Phone |
4 | Sr. Process Engineer | Reveal Email/Phone |
5 | Associate Scientist | Reveal Email/Phone |
6 | Staff Scientist | Reveal Email/Phone |
7 | Associate Scientist | Reveal Email/Phone |
Pearl Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Pearl Therapeutics?
Pearl Therapeutics is developing a pipeline of advanced respiratory products that will offer patients and their healthcare providers a choice of formulations and dosage strengths better suited to their needs. Pearl's products will afford multiple health benefits compared to current treatment options and will be available in familiar and widely used dosage forms to enhance compliance. The company has licensed advanced particle technology from Nektar Therapeutics and is developing it further for application in selected fields.
keywords:N/A$255.5M
Total Funding
44
Number of Employees
$4.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pearl Therapeutics News
... Novo Nordik, Sanofi, Unilife Corporation, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, Bend Research.
... in Dermatology: Clinical Trials, Therapeutics, and Care Management ... diversity representation was again referenced by Pearl E. Grimes,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.2M | 44 | 0% | N/A |
#2 | $3.5M | 45 | 5% | N/A |
#3 | N/A | 46 | 18% | N/A |
#4 | $9.9M | 46 | 5% | N/A |
#5 | $9.1M | 46 | 7% | N/A |